The Korean IPO market sees only one new listing in the second week of July, as Lemon Healthcare lists on the KOSDAQ on the 6th. The sparse activity continues the weak IPO market conditions observed in the first half of the year, according to the financial investment industry on the 6th. Lemon Healthcare, a bidirectional medical my-data relay platform company founded in 2017, raised 20 billion KRW at an IPO price of 10,000 KRW per share, the upper end of the indicative range.
Lemon Healthcare Lists on KOSDAQ with 20 Billion KRW Raise
Lemon Healthcare converts and provides patient medical data collected from hospitals in real time through its bidirectional medical my-data relay platform. The company plans to use the funds raised from the listing to build AI learning medical data distribution and trading infrastructure and to upgrade existing services. The institutional demand forecast attracted 2,233 institutions with a competition ratio of 1238 to 1, while the retail subscription competition ratio reached 1511 to 1. Subscription deposits totaled approximately 3.7764 trillion KRW. The expected market capitalization is approximately 133.5 billion KRW, with KB Securities serving as the listing lead manager.
TLB Conducts 120 Billion KRW Rights Offering for Vietnam Expansion
TLB, a semiconductor memory module printed circuit board (PCB) company, is conducting a 120 billion KRW shareholder allocation followed by general public offering of unsubscribed shares rights offering from the 6th to the 7th. All proceeds will be invested in the construction of a second factory in Vietnam and the establishment of a new PCB production line. The expansion aims to increase production capacity for high-value-added memory module substrates such as SOCAMM, demand for which is growing due to the spread of artificial intelligence (AI) servers. The rights offering is accompanied by a bonus issue allocating one share per existing share.
Hyungji I&C Proceeds with 13 Billion KRW Rights Offering
Hyungji I&C, a menswear company owning the shirt brand 'Yejak', is pursuing a shareholder allocation followed by general public offering of unsubscribed shares rights offering worth approximately 13 billion KRW from the 9th to the 10th. The funds raised will be used for operating funds and debt repayment. Hyungji I&C conducted a capital reduction in April, consolidating 10 ordinary shares into one share to improve its financial structure, before proceeding with the capital increase.
Clobot and Sensorview Approach Rights Offering Record Dates
Robot software company Clobot and telecommunications component company Sensorview will reach their rights offering record dates on the 7th and 8th respectively.
FAQ
What did Lemon Healthcare achieve in its KOSDAQ listing?
Lemon Healthcare listed on the KOSDAQ on the 6th, raising 20 billion KRW at an IPO price of 10,000 KRW per share, the upper end of the indicative range. The institutional demand forecast recorded a 1238 to 1 competition ratio with 2,233 institutions participating, while retail subscription reached 1511 to 1, drawing approximately 3.7764 trillion KRW in subscription deposits.
Why is TLB conducting a 120 billion KRW rights offering?
TLB is conducting the 120 billion KRW rights offering from the 6th to the 7th to fund the construction of a second factory in Vietnam and the establishment of a new PCB production line. The expansion targets increased production capacity for high-value-added memory module substrates such as SOCAMM, driven by growing demand from AI server proliferation.
How is Hyungji I&C using its rights offering proceeds?
Hyungji I&C plans to use the approximately 13 billion KRW raised from its rights offering (9th-10th) for operating funds and debt repayment. The company conducted a 10-to-1 share consolidation in April to improve its financial structure before proceeding with the capital increase.
